2025-07-25 - Analysis Report
Okay, here's an analysis of Hims & Hers Health Inc (HIMS) based on the provided data, presented as an English report with numbers first, followed by analysis.

## Hims & Hers Health Inc (HIMS) Analysis

**Ticker:** HIMS
**Company Overview:** Hims & Hers Health Inc. is a telehealth company that offers a variety of health and wellness products and services online.

### 1. Performance vs. S&P 500 (VOO)

*   **HIMS Cumulative Return:** 217.92%
*   **VOO Cumulative Return:** 67.47%
*   **Spread (HIMS - VOO):**
    *   **Current:** 150.45%
    *   **Max:** 288.9%
    *   **Min:** -88.4%
    *   **Current Relative Spread:** 53.0

**Analysis:** HIMS has significantly outperformed the S&P 500 (VOO) over the tracked period. The current spread of 150.45% indicates substantial outperformance. The relative spread of 53.0 suggests the current outperformance is in the middle range of its historical extremes.

### Alpha, Beta Analysis

| Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
|------------|--------|-------|--------|------|--------|
| 2019-2021  | -46.0% | 51.0% | -84.0% | -0.0 | 1.5    |
| 2020-2022  | -15.0% | 72.1% | -17.0% | -0.0 | 1.4    |
| 2021-2023  | -51.0% | 72.1% | -69.0% | -0.1 | 2.0    |
| 2022-2024  | 127.0% | 78.4% | 101.0% | -0.1 | 5.4    |
| 2023-2025  | 213.0% | 78.4% | 162.0% | -0.1 | 12.8   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows highly variable performance.  Early periods show significant negative growth, while recent periods (2022-2024 and 2023-2025) demonstrate very strong positive growth. This indicates a potentially high-growth, but volatile stock.
*   **MDD:** The Maximum Drawdown (MDD) is consistently high, indicating significant potential for loss. Investors should be aware of this volatility.
*   **Alpha:** The Alpha values are quite variable.  Early periods show negative alpha, indicating underperformance relative to the benchmark, while more recent periods show very high positive alpha, indicating significant outperformance.
*   **Beta:** The Beta is consistently negative and close to zero, suggesting HIMS has a very weak inverse correlation with the market (S&P 500).
*   **Cap:** The Market Capitalization (Cap) has grown significantly, especially in the most recent periods.

### 2. Recent Stock Price Movement

*   **Current Price:** 57.32
*   **Previous Close:** 58.02
*   **Change:** -1.21
*   **5-Day Moving Average:** 52.666
*   **20-Day Moving Average:** 50.1546
*   **60-Day Moving Average:** 52.1925

**Analysis:** The current price is slightly down compared to the previous close (-1.21). The 5-day moving average is above the 20-day and 60-day moving averages, suggesting a short-term upward trend. However, the 20-day moving average is below the 60-day moving average, which could indicate some underlying weakness.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3274 (Low Risk)
*   **RSI:** 65.64
*   **PPO:** 1.73
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **Delta_Previous_Relative_Divergence (20-day):** -1.3 (Negative - Short-term Decline)
*   **Expected Return (%):** -16.5%

**Analysis:**

*   **MRI:** The Market Risk Indicator suggests a low-risk environment.
*   **RSI:** The RSI of 65.64 is approaching overbought territory (typically above 70), suggesting the stock might be due for a pullback.
*   **PPO:** The Positive Price Oscillator (PPO) of 1.73 indicates a positive trend but is not extremely high.
*   **Hybrid Signal:** The hybrid signal recommends a cautious buy (80% of cash)
*   **Delta_Previous_Relative_Divergence:** The negative change in relative divergence indicates a recent short-term decline relative to the benchmark.
*   **Expected Return:** A negative expected return of -16.5% suggests that, based on the model, HIMS is expected to underperform the S&P 500 over a long-term (2+ year) investment horizon.
*   **Price Change Reflection:** The current price change of -1.21 reflects a recent slight drop in the stock price, contributing to the short-term negative divergence.

### 4. Recent News & Significant Events

*   **[2025-07-23]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-25]:** Analyst discussions regarding recent performance and outlook.
*   **[2025-07-24]:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-21]:** Market experts highlighting risks and opportunities, advising monitoring of news and announcements.

**Analysis:** The recent news indicates that HIMS is experiencing significant activity, including potential business developments, analyst scrutiny, and stock volatility. Investors should pay close attention to news releases and company announcements.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-05-05 | 0.22 | 0.59 B$   |
| 2024-11-04 | 0.35 | 0.40 B$   |
| 2024-08-05 | 0.06 | 0.32 B$   |
| 2024-05-06 | 0.05 | 0.28 B$   |
| 2025-05-05 | 0.05 | 0.28 B$   |

**Analysis:** The provided earnings data shows that **Revenue has been generally increasing over the past few quarters**. In particular, there was significant revenue growth in the most recent quarter (2025-05-05), reaching 0.59B$. However, there is duplicated data in this column.

### 6. Financial Information

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | $0.59B  | 73.50%        |
| 2024-12-31 | $0.48B  | 76.81%        |
| 2024-09-30 | $0.40B  | 79.16%        |
| 2024-06-30 | $0.32B  | 81.30%        |
| 2024-03-31 | $0.28B  | 82.36%        |

| Quarter    | Equity  | ROE     |
|------------|---------|---------|
| 2025-03-31 | $0.55B  | 9.01%   |
| 2024-12-31 | $0.48B  | 5.46%   |
| 2024-09-30 | $0.44B  | 17.18%  |
| 2024-06-30 | $0.36B  | 3.67%   |
| 2024-03-31 | $0.34B  | 3.23%   |

**Analysis:**

*   **Revenue:**  Revenue has been consistently increasing, demonstrating strong growth.
*   **Profit Margin:**  Profit margins have been decreasing in recent quarters. This trend may be a concern, as it indicates that the company's profitability is declining despite increased revenue.
*   **Equity:** Equity has been steadily increasing.
*   **ROE:**  Return on Equity (ROE) is volatile, with a significant spike in 2024-09-30.

### 7. Overall Summary

Hims & Hers Health Inc. (HIMS) has shown significant outperformance relative to the S&P 500, but with considerable volatility. Recent performance has been strong, with high growth in both CAGR and Market Capitalization. Recent news suggests significant activity and potential volatility. Revenue is growing, but declining profit margins are a concern. While the MRI indicates a low-risk environment, the RSI suggests the stock might be overbought, and the negative expected return indicates potential underperformance compared to the S&P 500 in the long term. The Hybrid signal recommends a cautious buy approach. The negative trend in the divergence also signals a short-term decline. Investors should closely monitor news, company announcements, and financial metrics to make informed decisions.
